ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,175Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 682

$1.13M Total Retail Price of All Prescriptions

Rank: 75 out of 682

502 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 11,014 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,259 665 S3 1 1
LEVOTHYROXINE SODIUM 491 373 2 3
FUROSEMIDE 473 333 3 7
OMEPRAZOLE 392 251 4 5
LISINOPRIL 363 255 5 2
ATORVASTATIN CALCIUM 347 241 6 11
SIMVASTATIN 329 256 7 4
METOPROLOL SUCCINATE 327 224 8 16
TRAMADOL HCL 320 207 9 26
POTASSIUM CHLORIDE 320 205 9 14
GABAPENTIN 319 163 11 9
CITALOPRAM HBR 313 220 12 17
CRESTOR 237 128 13 22
COMBIVENT 193 81 14 105
METFORMIN HCL 182 98 15 8
CARVEDILOL 178 154 16 23
AMLODIPINE BESYLATE 175 135 17 6
ALLOPURINOL 170 156 18 32
PANTOPRAZOLE SODIUM 165 112 19 29
OXYCODONE HCL 161 61 S2 20 93
LEVOFLOXACIN 154 108 21 70
ISOSORBIDE MONONITRATE ER 151 109 22 31
ATENOLOL 150 99 23 18
WARFARIN SODIUM 148 132 24 13
LYRICA 146 77 25 78
METFORMIN HCL ER 146 95 25 68
POLYETHYLENE GLYCOL 3350 144 126 27 44
NEXIUM 143 76 28 19
PROAIR HFA 142 54 29 45
DONEPEZIL HCL 141 110 30 30
METOPROLOL TARTRATE 138 99 31 10
DIGOXIN 135 92 32 46
GLIMEPIRIDE 134 83 33 43
NAMENDA 133 129 34 41
TIZANIDINE HCL 121 29 35 83
FLUTICASONE PROPIONATE 120 93 36 36
ADVAIR DISKUS 118 58 37 47
ALENDRONATE SODIUM 115 101 38 37
TRAZODONE HCL 114 52 39 38
SYMBICORT 108 52 40 117
OXYCODONE HCL-ACETAMINOPHEN 107 0 S2 41 98
SERTRALINE HCL 102 72 42 24
CYMBALTA 101 51 43 51
ZOLPIDEM TARTRATE 100 48 44 21
HYDROCHLOROTHIAZIDE 98 57 45 12
VENTOLIN HFA 97 61 46 101
LOSARTAN POTASSIUM 86 56 47 20
RANITIDINE HCL 86 55 47 28
PRAVASTATIN SODIUM 86 57 47 15
CYCLOBENZAPRINE HCL 80 22 R 50 65
ESCITALOPRAM OXALATE 78 55 51 73
SPIRONOLACTONE 77 65 52 64
PREDNISONE 77 55 52 40
DICLOFENAC SODIUM 76 37 54 107
FENTANYL 76 63 S2 54 86
QUETIAPINE FUMARATE 75 13 56 87
OXYCODONE-ACETAMINOPHEN 73 39 S2 57 120
ONDANSETRON HCL 72 45 58 195
DILTIAZEM 24HR CD 71 71 59 123
JANUVIA 70 56 60 62
DIOVAN 70 66 60 42
BUSPIRONE HCL 68 38 62 102
MELOXICAM 67 30 63 27
LOVAZA 66 28 64 106
METOCLOPRAMIDE HCL 65 55 65 111
LEVETIRACETAM 65 63 65 125
BUPROPION HCL SR 63 20 67 198
TAMSULOSIN HCL 63 59 67 33
METHYLPREDNISOLONE 61 39 69 127
CLOPIDOGREL 60 50 70 25
SPIRIVA 59 20 71 49
MIRTAZAPINE 57 36 72 52
GALANTAMINE HBR 56 56 73 288
PLAVIX 54 40 74 35
CARISOPRODOL 54 0 R 74 146
AZITHROMYCIN 54 33 74 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 35 77 34
RISPERIDONE 53 25 77 82
MORPHINE SULFATE ER 51 0 S2 79 143
TOPIRAMATE 51 11 79 150
CIPROFLOXACIN HCL 50 30 81 58
LIDODERM 50 0 81 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.